Simulations Plus, Inc., a leading provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, announced that several regulatory agencies around the world have added licenses of the best-in-class GastroPlus and ADMET Predictor software within the past three months.

The company has received orders from: The National Institutes for Food and Drug Control in China;  The Pharmaceutical and Medical Devices Agency in Japan;  The US Food and Drug Administration;  The Environmental Protection Agency.

John DiBella, vice president for marketing and sales for Simulations Plus, said: “We are very pleased that the use of our modeling and simulation technology continues to expand throughout various divisions and departments at regulatory agencies around the globe. We plan to host training workshops at several agencies over the coming months to ensure that researchers are educated on the latest developments and to maintain an open dialogue to receive feedback and identify potential new applications. There has been a significant push from regulatory groups to industry on the adoption of modeling and simulation to more effectively design and develop new drugs and products, and we look forward to supporting these efforts.”

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation and modeling software which is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, agrochemical, and food industry companies worldwide.